Possible explanations for an elevated AST/ALT ratio leading to a higher risk of ACM in stable CAD patients are as follows: previous studies have shown that high AST activity is associated with higher mortality32,33, and low ALT levels are associated with aging, frailty, and higher mortality, in elderly populations34. The gene discussed is GPT; the disease is coronary artery disorder.